Towards reproducible computational drug discovery
- PMID: 33430992
- PMCID: PMC6988305
- DOI: 10.1186/s13321-020-0408-x
Towards reproducible computational drug discovery
Abstract
The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code.
Keywords: Bioinformatics; Cheminformatics; Data science; Data sharing; Drug design; Drug discovery; Open data; Open science; Reproducibility; Reproducible research.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
APRICOT: Advanced Platform for Reproducible Infrastructures in the Cloud via Open Tools.Methods Inf Med. 2020 Dec;59(S 02):e33-e45. doi: 10.1055/s-0040-1712460. Epub 2020 Aug 10. Methods Inf Med. 2020. PMID: 32777825 Free PMC article.
-
Computational reproducibility of Jupyter notebooks from biomedical publications.Gigascience. 2024 Jan 2;13:giad113. doi: 10.1093/gigascience/giad113. Gigascience. 2024. PMID: 38206590 Free PMC article.
-
A Guide and Toolbox to Replicability and Open Science in Entomology.J Insect Sci. 2020 May 1;20(3):6. doi: 10.1093/jisesa/ieaa036. J Insect Sci. 2020. PMID: 32441307 Free PMC article. Review.
-
TeachOpenCADD 2022: open source and FAIR Python pipelines to assist in structural bioinformatics and cheminformatics research.Nucleic Acids Res. 2022 Jul 5;50(W1):W753-W760. doi: 10.1093/nar/gkac267. Nucleic Acids Res. 2022. PMID: 35524571 Free PMC article.
-
Publishing computational research - a review of infrastructures for reproducible and transparent scholarly communication.Res Integr Peer Rev. 2020 Jul 14;5:10. doi: 10.1186/s41073-020-00095-y. eCollection 2020. Res Integr Peer Rev. 2020. PMID: 32685199 Free PMC article. Review.
Cited by
-
Traditional Machine and Deep Learning for Predicting Toxicity Endpoints.Molecules. 2022 Dec 26;28(1):217. doi: 10.3390/molecules28010217. Molecules. 2022. PMID: 36615411 Free PMC article.
-
Theoretical Studies on the Molecular Properties, Toxicity, and Biological Efficacy of 21 New Chemical Entities.ACS Omega. 2021 Sep 15;6(38):24891-24901. doi: 10.1021/acsomega.1c03736. eCollection 2021 Sep 28. ACS Omega. 2021. PMID: 34604670 Free PMC article.
-
Computational drug discovery on human immunodeficiency virus with a customized long short-term memory variational autoencoder deep-learning architecture.CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):308-316. doi: 10.1002/psp4.13085. Epub 2023 Dec 5. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38010989 Free PMC article.
-
Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η.Sci Rep. 2022 Nov 2;12(1):18461. doi: 10.1038/s41598-022-22810-z. Sci Rep. 2022. PMID: 36323739 Free PMC article.
-
Measuring the Impact of Data Sharing: From Author-Level Metrics to Quantification of Economic and Non-tangible Benefits.Cureus. 2023 Dec 11;15(12):e50308. doi: 10.7759/cureus.50308. eCollection 2023 Dec. Cureus. 2023. PMID: 38205488 Free PMC article. Review.
References
-
- Stratmann HG. Bad medicine: when medical research goes wrong. Analog Sci Fict Fact. 2010;CXXX(9):20–30.
-
- Biotechnology Innovation Organisation (2016) Clinical Development Success Rates 2006–2015
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources